Qiang Xu

Qiang Xu, Ph.D.
Partner

Dr. Qiang Xu is a Partner at Decheng Capital and has been with the firm since its inception. He is currently serving on the boards of Ark Biosciences, BCFoods, GYT HealthCare Services, IMPACT Therapeutics, KeChow Pharma and Kind Pharmaceutical.

Dr. Xu has over 14 years of experience from biotechnology start-ups to pharmaceutical companies and also has extensive experience in agricultural biotechnology. Dr. Xu started his as a scientist at Bayer, and then joined Scios as a member of the Alzheimers Disease Discovery Program. He worked at Pan Pacific Pharmaceuticals as a director, before he joined Osel as Vice President of Research and the principal investigator for multiple grants funded by the NIH and other foundations. He has published over 30 peer reviewed papers, and 50 conference presentations, and is the co-inventor of 10 patents or applications.

Dr. Xu received his BS in agronomy and MS in Crop Sciences (with Professor Yu Songlie, an academician of the Chinese Academy of Engineering) and PhD in plant physiology from Kansas State University. He completed his postdoctoral training at the University of California, Berkeley.

 

Min Cui, Ph.D.
Managing Director
Victor E. Tong, Jr.
Partner
Nick Pliam, M.D., Ph.D.
Partner
Y. Katherine Xu, Ph.D.
Partner
Qiang Xu, Ph.D.
Partner
Wei Xu
Partner
Peter Colabuono
Principal
Tony Tong, Ph.D.
Principal
Aaron Li, MBA
Vice President
Yang Lu, MBA
Vice President
Dan Zabrowski, Ph.D.
Venture Partner
 
Copyright ? 2011 Decheng Capital LLC. All Rights Reserved.
poronovideos少妇_藏经阁福利导福航_青青国产揄拍视频